Alzheimer's Diagnosis
Seiten
2012
Nova Science Publishers Inc (Verlag)
978-1-61209-846-3 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-61209-846-3 (ISBN)
Presents topical research on Alzheimer's diagnosis including cerebrospinal fluid biomarker Amyloid-B 1-42 identification; visual impairment in Alzheimer's disease; and, cerebral glucose metabolism through F-fluoro-deoxy-glucose positron emission tomography and neuroimaging.
The demographics of ageing suggest a great need for an early diagnosis of dementia and for the development of preventive strategies. Neurodegeneration in Alzheimer's disease is estimated to start 20-30 years before clinical onset, and the identification of biological markers for pre-clinical and early diagnosis is the principal aim of research studies in the field. In this book, the authors present topical research on Alzheimer's diagnosis including cerebrospinal fluid biomarker Amyloid-B 1-42 identification; visual impairment in Alzheimer's disease; cerebral glucose metabolism through F-fluoro-deoxy-glucose positron emission tomography and neuroimaging.
The demographics of ageing suggest a great need for an early diagnosis of dementia and for the development of preventive strategies. Neurodegeneration in Alzheimer's disease is estimated to start 20-30 years before clinical onset, and the identification of biological markers for pre-clinical and early diagnosis is the principal aim of research studies in the field. In this book, the authors present topical research on Alzheimer's diagnosis including cerebrospinal fluid biomarker Amyloid-B 1-42 identification; visual impairment in Alzheimer's disease; cerebral glucose metabolism through F-fluoro-deoxy-glucose positron emission tomography and neuroimaging.
Preface; Quantitation of Amyloid-ss Oligomers in Human Body Fluids for Alzheimer's Disease Early Diagnosis or Therapy Monitoring?; Visual Impairment in Alzheimer Disease: Clinical, Pathophysiological & Instrumental Aspects; Alzheimer's Disease Diagnosis: A New Approach; Mitochondrial Haplogroups Associated with Japanese Alzheimer's Patients; Leading Role & Limits of 18F-FDG-PET Imaging in Early Diagnosis of Alzheimer's Disease; Artificial Neural Networks in Alzheimer's Diagnosis: A Perspective; Milestones & Difficulties in Alzheimer's Disease Diagnosis; The Role of Neuroimaging in the Early Diagnosis of Alzheimer's Disease; Cerebrospinal Fluid Biomarkers for Alzheimer's Disease; Index.
| Verlagsort | New York |
|---|---|
| Sprache | englisch |
| Maße | 230 x 155 mm |
| Gewicht | 540 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie | |
| ISBN-10 | 1-61209-846-0 / 1612098460 |
| ISBN-13 | 978-1-61209-846-3 / 9781612098463 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
das gesamte Spektrum der Altersmedizin für Klinik und Praxis
Buch | Hardcover (2024)
Kohlhammer (Verlag)
CHF 259,95
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen
Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
CHF 51,80
